Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Six-month Eligard product completes phase III trial

Nov. 13, 2003

Lilly scientists discover new ERbeta agonists for use in prostate cancer

Nov. 13, 2003

Phase II dose-to-rash study of Tarceva

Nov. 12, 2003

Eligard products receive Canadian approval

Nov. 12, 2003

Hybrigenics and Servier sign new drug discovery agreements

Nov. 11, 2003

New ErbB kinase inhibitors, their preparation and use revealed in AstraZeneca patent

Nov. 11, 2003

BMS researchers present new protein kinase inhibitors for proliferative and inflammatory disorders

Nov. 11, 2003

Xcytrin evaluated in combination with Rituxan and Zevalin

Nov. 10, 2003

New EGFR inhibitors discovered at Boehringer Ingelheim

Nov. 10, 2003

Good efficacy and safety profile reported for arzoxifene in hormone-sensitive breast cancer

Nov. 10, 2003

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...